Metabolic profile alterations as early indicators of gastrointestinal stromal tumors (GISTs) recurrence and imatinib resistance.
Saved in:
| Title: | Metabolic profile alterations as early indicators of gastrointestinal stromal tumors (GISTs) recurrence and imatinib resistance. |
|---|---|
| Authors: | Luo AL; Department of Medicine, Keck Medicine of USC, Los Angeles, CA, USA., Seylani A; Department of Medicine, Cleveland Clinic, Cleveland, OH, USA., Haile Y; UC Riverside School of Medicine, Riverside, CA, USA., Sadighian A; UC Riverside School of Medicine, Riverside, CA, USA., Sadighian S; UC Riverside School of Medicine, Riverside, CA, USA., Agulnik M; Division of Oncology, Department of Medicine, Keck Medicine of USC, Los Angeles, CA, USA. |
| Source: | Journal of gastrointestinal oncology [J Gastrointest Oncol] 2026 Jun 30; Vol. 17 (3), pp. 139. Date of Electronic Publication: 2026 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
